Eyepoint Pharmaceuticals Inc (OQ:EYPT)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for EYPT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 24th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 15/19 May 13/19 Landis John B. Direct Ownership Common Stock P - Open market or private purchase 40,000 $1.74
Apr 16/19 Apr 12/19 Duker Jay S. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -20,000  
Apr 16/19 Apr 12/19 Duker Jay S. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,000 $1.77
Apr 3/19 Apr 1/19 Duker Jay S. Direct Ownership Common Stock P - Open market or private purchase 5,000 $1.89
Apr 2/19 Apr 1/19 Ross Leonard S Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -5,000  
Apr 2/19 Apr 1/19 Ross Leonard S Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,000 $1.81
Apr 1/19 Mar 29/19 Lurker Nancy Direct Ownership Common Stock P - Open market or private purchase 28,500 $1.76
Apr 1/19 Mar 29/19 Mazzo David J Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -20,000  
Apr 1/19 Mar 29/19 Mazzo David J Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,000 $1.77
Apr 1/19 Mar 29/19 Godshall Douglas Evan Direct Ownership Common Stock P - Open market or private purchase 17,000 $1.75
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for EYPT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 24th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 15/19 May 13/19 Landis John B. Direct Ownership Common Stock P - Open market or private purchase 40,000 $1.74
Apr 16/19 Apr 12/19 Duker Jay S. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -20,000  
Apr 16/19 Apr 12/19 Duker Jay S. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,000 $1.77
Apr 3/19 Apr 1/19 Duker Jay S. Direct Ownership Common Stock P - Open market or private purchase 5,000 $1.89
Apr 2/19 Apr 1/19 Ross Leonard S Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -5,000  
Apr 2/19 Apr 1/19 Ross Leonard S Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,000 $1.81
Apr 1/19 Mar 29/19 Lurker Nancy Direct Ownership Common Stock P - Open market or private purchase 28,500 $1.76
Apr 1/19 Mar 29/19 Mazzo David J Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -20,000  
Apr 1/19 Mar 29/19 Mazzo David J Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,000 $1.77
Apr 1/19 Mar 29/19 Godshall Douglas Evan Direct Ownership Common Stock P - Open market or private purchase 17,000 $1.75
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $EYPT

StockTwits